France Animal Healthcare Market Trends, Share, Revenue, Scope, Challenges, Future Investment and Growth Opportunities Till 2033

Share

France Animal Healthcare Market Trends, Share, Revenue, Scope, Challenges, Future Investment and Growth Opportunities Till 2033: SPER Market Research


 Category : Healthcare

 Published: Dec-2023
 Author: SPER Analyst


France Veterinary Healthcare Market is estimated to reach USD XX billion by 2033 with a CAGR of 4.31%.

Veterinary healthcare includes early detection and treatment of disease symptoms in addition to medical testing done to safeguard the well-being and productivity of animals. Animal biopsies, urine, faeces, and blood are among the many methods used to conduct the testing. Numerous animals, both domestic and wild, can be diagnosed by veterinarians. New animal disease strains and their subsequent human-to-animal transmission through animal-to-animal contact and animal-to-food consumption are driving the industry's growth. The science pertaining to the identification, management, and avoidance of illnesses in animals is known as veterinary medicine.

France Veterinary Healthcare Market Driving Factors and Challenges

The primary driver of veterinary healthcare market is the growing need to reduce chronic and zoonotic diseases in pets and livestock. Over the past few decades, there has been a sharp increase in the number of livestock worldwide. The demand for cattle products is rising in France's developing nations. Furthermore, it is projected that in the near future, there will be a rise in demand for veterinary medications and vaccinations for the livestock population due to growing worries about food security and animal husbandry. Technological developments in veterinary healthcare are driving the regional market, and this is expected to present growth prospects in the future. These developments include vaccination banks, mobile technologies for animal owners, and the introduction of effective information management systems. A strong emphasis on innovation in animal health has led to the implementation of some policies that are enhancing the chances for market expansion. One public-private partnership that supports collaborative research to increase innovation in veterinary drugs in France is the Innovative Medicines Initiative (IMI).


Still, the market growth is hampered because of the factors like funding and infrastructure shortages, the use of fake medications, and the growing expense of veterinary care. Another major issue that could prevent the market from expanding in the upcoming years is the growing cost of veterinary care and animal testing. The lack of agricultural land and the rising demand for farming areas are predicted to limit market expansion. Also, the lack of some vaccines to protect against infections carried by livestock vectors slows down the market's rate of expansion. The market's growth pace is constrained by fluctuations in raw material availability and the lack of vaccinations for specific diseases. Furthermore, more stringent regulations on antibiotics are anticipated to continue to be a significant market barrier. In addition, increasing animal testing-related cost regulations provide a serious barrier to the expansion of the veterinary healthcare industry.

Impact of COVID-19 on France Veterinary Healthcare Market
In France, where only urgent and emergency care was permitted, the COVID-19 pandemic had a significant negative influence on veterinary services. This resulted in a significant loss of patients and income. Numerous vets had experienced medical and psychological ailments linked to the pandemic, financial constraints, seclusion, and the infection's long-term repercussions. Reductions in the number of diagnostic tests and treatments conducted were one of the negative effects of the COVID-19 pandemic regulations on the veterinary healthcare industry. The veterinary healthcare market's growth was influenced by this decline.

France Veterinary Healthcare Market Key Players:
The market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players such as; Boehringer Ingelheim International GmbH, Ceva Animal Health, Inc., Elanco, IDEXX Laboratories, Merck & Co. Inc., Vetoquinol, Zoetis Inc., Others.


France Veterinary Healthcare Market Segmentation:

By Product: Based on the Product, France Veterinary Healthcare Market is segmented as; Diagnostics (Clinical Chemistry, Diagnostic Imaging, Immunodiagnostic Tests, Molecular diagnostics, Other Diagnostics), Therapeutics (Vaccines, Parasiticides, Anti-infectives, Medical Feed Additives, Other Therapeutics).

By Animal Type: Based on the Animal Type, France Veterinary Healthcare Market is segmented as; Dogs and Cats, Horses, Poultry, Ruminants, Swine, Other Animals.

By Region: This research also includes data for Central Region, Northern Region, Southern Region.

This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.

Join Our SPER Panel

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-SIEMENS
SPER-LOREAL
SPER-Pfizer
SPER-IPSOS
SPER-Heineken
SPER-IQVIA
SPER-Kankar IMRB
SPER-PWC
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-SIEMENS
SPER-LOREAL
SPER-Pfizer
SPER-IPSOS
SPER-Heineken
SPER-IQVIA
SPER-Kankar IMRB
SPER-PWC

SPER

Market Research

We are the leading, full-service global market research and consulting company.

Certificates
iso-1 iso-1 iso-1 ESOMAR
Secure Payments
SPER Payment Options
Contact HR

 [email protected]

 +91-742-898-5650